PACB

Pacific Biosciences of California, Inc.

8.80 USD
+0.01 (+0.11%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Pacific Biosciences of California, Inc. stock is up 42.39% since 30 days ago. The next earnings date is Feb 15, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 64.29% of the previous 13 November’s closed higher than October. In the last 10 Unusual Options Trades, there were 8 CALLs, 2 PUTs. 75% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
16 Nov 19:16 19 Jan, 2024 8.00 CALL 515 8256
17 Nov 20:36 15 Dec, 2023 8.00 CALL 858 795
17 Nov 20:38 15 Dec, 2023 9.00 CALL 707 1185
20 Nov 18:03 19 Jan, 2024 9.00 PUT 211 423
20 Nov 20:35 15 Dec, 2023 7.00 CALL 168 251
21 Nov 16:11 19 Jan, 2024 7.00 CALL 250 152
21 Nov 20:08 19 Jan, 2024 7.00 CALL 150 152
22 Nov 19:24 19 Jan, 2024 8.00 CALL 965 9119
28 Nov 17:12 15 Dec, 2023 8.00 PUT 1000 142
29 Nov 20:33 15 Dec, 2023 7.00 CALL 177 421

About Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. PacBio's Systems conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow.

  • UBS
    Fri Nov 17, 07:18
    buy
    upgrade
  • Piper Sandler
    Mon Nov 6, 10:15
    hold
    confirm
  • Canaccord Genuity
    Tue Oct 31, 14:19
    buy
    confirm
  • Cantor Fitzgerald
    Tue Oct 31, 10:35
    buy
    upgrade